Table 4.

Applied treatment in study groups (survived vs. died).

Number (%)	Survived (n = 27)	Died (n = 18)	p in Chi-Square Test
COVID-19 convalescent plasma	7 (26.92%)	4 (23.53%)	0.803
Tocilizumab	2 (8%)	1 (5.88%)	0.793
Remdesivir	5 (19.23%)	6 (33.33%)	0.288
Steroid therapy	27 (100%)	16 (88.88%)	0.076
Anticoagulants	24 (92.30%)	13 (72.22%)	0.073
Immunoglobulins	7 (25.92%)	8 (44.44%)	0.196
Muscle relaxants	11 (40.74%)	10 (55.55%)	0.329